Close the sale of the travel health business to Bavarian Nordic
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 15 Feb 2023
- Due
- 30 Jun 2023
- Delivered
- 15 May 2023
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The transaction is expected to close in the second quarter of 2023, subject to regulatory clearance and customary closing conditions.”
What we found
Evidence strength A What the grades mean
Emergent BioSolutions completed the sale of its travel health business to Bavarian Nordic on May 15, 2023, which is within the second quarter of 2023.
-
A Emergent BioSolutions Inc. 10-Q filed 2023-08-09
“On May 15, 2023, pursuant to the Purchase and Sale Agreement, we completed the previously announced sale to Bavarian Nordic of our travel health business” ✓ confirmed on the page
Market reaction: the shares moved -23.2% against the S&P 500 over the three sessions around the disclosure (8 Aug 2023 to 11 Aug 2023). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Acquisition close
- Indicative materiality
- High rules
- Action
- Close
- Deliverable
- Sale of travel health business
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: subject to regulatory clearance; customary closing conditions
- Depends on
- Regulatory, Counterparty
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Emergent BioSolutions Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2023-EBS-002479 · Corrections policy